[
  {
    "ts": "2025-08-25T13:36:49+00:00",
    "headline": "Figma initiated, Okta upgraded: Wall Street's top analyst calls",
    "summary": "Figma initiated, Okta upgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/figma-initiated-okta-upgraded-wall-133649282.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "5976defc-352a-32fe-8372-7fad14a13db7",
      "content": {
        "id": "5976defc-352a-32fe-8372-7fad14a13db7",
        "contentType": "STORY",
        "title": "Figma initiated, Okta upgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "Figma initiated, Okta upgraded: Wall Street's top analyst calls",
        "pubDate": "2025-08-25T13:36:49Z",
        "displayTime": "2025-08-25T13:36:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/figma-initiated-okta-upgraded-wall-133649282.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/figma-initiated-okta-upgraded-wall-133649282.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SYM"
            },
            {
              "symbol": "MKTX"
            },
            {
              "symbol": "MIR"
            },
            {
              "symbol": "SI"
            },
            {
              "symbol": "ARGNF"
            },
            {
              "symbol": "ARGX"
            },
            {
              "symbol": "AAL"
            },
            {
              "symbol": "OKTA"
            },
            {
              "symbol": "FIG"
            },
            {
              "symbol": "AMBQ"
            },
            {
              "symbol": "FN"
            },
            {
              "symbol": "ALK"
            },
            {
              "symbol": "TTC"
            },
            {
              "symbol": "S"
            },
            {
              "symbol": "DGX"
            },
            {
              "symbol": "AEO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-25T12:52:00+00:00",
    "headline": "FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics",
    "summary": "Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company's Haystack MRD® test for identifying MRD-positive patients with stage II colorectal cancer following curative-intent surgical treatment who may benefit from adjuvant therapy in accordance with therapeutic product labeling.",
    "url": "https://finance.yahoo.com/news/fda-grants-breakthrough-device-designation-125200186.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "d0a02d28-1355-3416-aa38-2b8b03b97f83",
      "content": {
        "id": "d0a02d28-1355-3416-aa38-2b8b03b97f83",
        "contentType": "STORY",
        "title": "FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics",
        "description": "",
        "summary": "Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company's Haystack MRD® test for identifying MRD-positive patients with stage II colorectal cancer following curative-intent surgical treatment who may benefit from adjuvant therapy in accordance with therapeutic product labeling.",
        "pubDate": "2025-08-25T12:52:00Z",
        "displayTime": "2025-08-25T12:52:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b",
          "originalWidth": 400,
          "originalHeight": 190,
          "caption": "Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FuRCtrLWo1T4qYYDhuscJw--~B/aD0xOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b.cf.webp",
              "width": 400,
              "height": 190,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L_XnLitlJHZ7Gn01q1kijg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-grants-breakthrough-device-designation-125200186.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-grants-breakthrough-device-designation-125200186.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]